title: Future Therapies in Obesity.
abstract: Although diet and exercise have been the cornerstone of therapy for obesity, efficacy is suboptimal and short lived. Surgical procedures are durable but invasive therapy for obesity. Supplemental therapies for obesity that are minimally invasive, low risk, and effective are needed. Several therapeutic options are being developed that offer obese patients and their health care providers alternatives to what is currently available.
authors.affiliation: GI Nutrition, Obesity and Celiac Disease Program, Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, 3400 Convention Avenue, 4 South, Philadelphia, PA 19104, USA. Electronic address: octavia.pickett-blakely@uphs.upenn.edu.
authors.forename: Octavia
authors.initials: O
authors.lastname: Pickett-Blakely
authors.affiliation: Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
authors.forename: Carolyn
authors.initials: C
authors.lastname: Newberry
mesh_terms: D019440:Anti-Obesity Agents / Q000627:therapeutic use; D050110:Bariatric Surgery / Q000379:methods; D057005:Bioengineering; D003131:Combined Modality Therapy; D000529:Complementary Therapies / Q000379:methods; D004599:Electric Stimulation Therapy / Q000379:methods; D016099:Endoscopy, Gastrointestinal / Q000379:methods; D000069467:Fecal Microbiota Transplantation; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D009765:Obesity / Q000382:microbiology / Q000628:therapy*; D056692:Prebiotics; D019936:Probiotics / Q000627:therapeutic use; D035703:Therapies, Investigational
chemical_list: D019440:Anti-Obesity Agents; D056692:Prebiotics
keywords: Complementary/alternative therapies; Endobariatrics; Genetics; Microbiome; Obesity; Pharmacotherapy